Are Pfizer and Moderna Exaggerating the Effectiveness of their Corona Virus Vaccines?

Executive Summary

• Pfizer and Moderna are providing exaggerated information to the public about their coronavirus vaccines.
• This is having a deleterious effect on international policies for managing the coronavirus.

Introduction

Much has been made of the announced coronavirus vaccines by Pfizer and Moderna.

Our References

See our references for this article and related articles at this link.

The coverage of the vaccine by the establishment media has been brainless. It simply presumes the vaccine will work and does not ask how the vaccine was developed so fast. 

The US Government is buying large quantities of vaccines from pharma companies without much evidence of how well they work. 

Stock Speculation on Stocks of the Pharma Companies That Announced the Corona Virus Vaccines

Both executives at Pfizer and Moderna both sold large amounts of stock right after their stocks went up due to announcing vaccines for the coronavirus.

Whether the coronavirus vaccine developed by Moderna succeeds or not, executives at the small biotech company have already made tens of millions of dollars by cashing in their stock. An NPR examination of official company disclosures has revealed additional irregularities and potential warning signs.

“On a scale of one to 10, one being less concerned and 10 being the most concerned,” said Daniel Taylor, an associate professor of accounting at the Wharton School, “this is an 11.”

Taylor said Moderna’s stock-selling practices appear well outside the norm, and raise questions about the company’s internal controls to prevent insider trading.

Since January, CEO Stéphane Bancel has sold roughly $40 million worth of Moderna stock held by himself or associated investment funds; Chief Medical Officer Tal Zaks has sold around $60 million; and President Stephen Hoge has sold more than $10 million.

No clear evidence has emerged indicating that executives sold stock based on confidential internal information, which would be illegal. And as long as they don’t engage in insider trading, executives are typically free to sell company stock. – NPR

This also raises the question of why the executives would do this if they were confident that the vaccine would be effective. Moderna executives do not need to release a vaccine to make millions; they only need to make an announcement. Then later, when the vaccine does not work, they can declare that they thought it would work, but it didn’t.

And the type of stock sales looks particularly suspicious, as explained in the following quotation.

Here’s what NPR’s examination found:

Stock Sales Worth Tens Of Millions: Since June 1, NPR has found, company executives have sold roughly $90 million worth of Moderna stock. Rather than put a hold on the trades after facing intense criticism in May, company executives continued to sell.

Questionable Modifications To Stock Sale Plans: Moderna says its executives pre-scheduled their stock sales long in advance. Those schedules – known as 10b5-1 plans – can act as a defense to charges of insider trading. But the plans have to be put in place when executives do not have confidential inside information. NPR has found multiple executives adopted or modified their plans just before key announcements about the company’s vaccine. That has raised questions about whether they were aware of nonpublic information when they planned their stock trades.

Selling To Zero: Generally, corporate best practices suggest that a company’s leadership should hold on to at least some stock in their company to have “skin in the game.” That way, the thinking goes, an executive has an incentive to improve the company’s performance. As Moderna has been developing its coronavirus vaccine, two executives, including the Chief Medical Officer, have sold all their stock holdings in the company. The General Counsel has sold nearly all of her holdings. – NPR

Again, if the vaccine is effective, the stock price will only rise further. The selling of all stock by some of the executives indicates a lack of confidence in the vaccine. Again, Moderna need not have developed a working vaccine.

This is straight-up insider trading. And if the Moderna vaccines turn out to be ineffective, there is a strong case to prosecute the Moderna executives. The fact that so much is being pinned on this company, which is performing a pump-and-dump stock scam, should be a major red flag.

This fact has not been widely distributed as a news story, and when it has, it has been presented in the business press and is not included in the stories about the effectiveness of the vaccines.

This 60 minute Australian program was aired in May of 2020. In this program, professor Authur Caplan called into question the estimated 12 months to obtain a vaccine for coronavirus. Now, in December, seven months after he made this statement, the virus has arrived. But does it work? 

The point made by Caplan is that Moderna has never had any drug approved. Yet it is assumed that Moderna’s vaccine will be effective.

The information communicated by Caplan in this video, which explains the general duration of the development of vaccines in the past, is not being communicated to the public. Instead, the public is being fed overly optimistic projections by politicians.

Trump has been one of the politicians creating an overly rosy scenario of the impact of vaccines. 

The virus, they are working hard, it looks like by April it miraculously goes away.

This statement by Trump seems to presume that a vaccine for a virus can be developed in just a few months, which is false.

*Political Disclaimer*

The author is neither a Republican voter nor a Democratic voter and has a history of piling on large amounts of criticism on both parties. The author opposes corruption and ineptitude and calls it out no matter the country or the individual’s political affiliation.

How The FDA Not Doing its Job on the Vaccines

The FDA has been increasingly tolerant of pharmaceutical companies making claims in the press rather than first submitting the tests to the FDA. Suppose we have a health system that departs from the scientific method and is driven by the stock incentives of the executives in pharmaceutical companies. In that case, we will have an unending series of false-positive results.

The negative reactions from the vaccines that are being tested are already streaming in.

Media outlets are reporting that two individuals who received the Pfizer-BioNTech COVID-19 mRNA vaccine developed severe anaphylactic reactions following the injection.

England’s National Health Service (NHS) warned Wednesday that people “with a history of a significant allergic reaction to a vaccine, medicine or food” should not be given the COVID-19 vaccine developed by U.S. pharmaceutical giant Pfizer and Germany’s BioNTech. UK’s Medical and Health products Regulatory Agency, as reported by The Wall Street Journal, reminded health-care workers that vaccinations should only be carried out in facilities where resuscitation measures are available.

What is concerning about the response is the fact that in the letter we acknowledge that we had already reached out to Moderna’s scientists regarding the use of PEG and lack of informing vaccine trial recipients about the use of PEG in the vaccine, soliciting a history of PEG allergies and testing blood antibody levels to PEG.

Did the FDA officials actually read the letter?

CHD’s concerns about PEG stem from the fact that PEG-specific immune responses can actually reduce the efficacy of vaccines and increase the occurrence of adverse events.

“As Moderna’s mRNA-1273 candidate vaccine uses a PEGylated LNP vector, what procedures are included in the trial to mitigate this risk?”